[1] More broadly, the delayed gastric emptying caused by these medications may affect the absorption timing of some oral medications
This means retatrutide is currently only available for research purposes through specialized suppliers
The exception: people coming from tirzepatide or semaglutide If you have been on semaglutide or tirzepatide and are transitioning to retatrutide, your body already has significant adaptation to GLP-1 and possibly GIP receptor activation
The violent agitation and shearing forces can fracture the peptide bonds or cause the molecules to aggregate into useless clumps
You can view the complete structural layout and Technical specifications on our product page
They're designed to: Confirm the weight loss and metabolic benefits seen in Phase 2 Identify rare side effects that smaller trials might have missed Demonstrate consistent results across diverse populations (age, sex, ethnicity, comorbidities) Build long-term safety data (cardiovascular outcomes, liver health, kidney function) Provide the evidence package the FDA needs to approve the drug Retatrutide's Phase 2 results were strong enough (up to 24.2% weight loss) that Eli Lilly moved it into a large Phase 3 program
